Cargando…

An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection

BACKGROUND: The use of octreotide prophylaxis following pancreatic surgery is controversial. We aimed to evaluate the effectiveness of octreotide for the prevention of postoperative complications after pancreatic surgery through this systematic review and meta-analysis. METHODS: Literature databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hao, Qin, Jiwei, Wang, Ning, Chen, Wanjing, Huang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756593/
https://www.ncbi.nlm.nih.gov/pubmed/31567967
http://dx.doi.org/10.1097/MD.0000000000017196
_version_ 1783453426080808960
author Zheng, Hao
Qin, Jiwei
Wang, Ning
Chen, Wanjing
Huang, Qiang
author_facet Zheng, Hao
Qin, Jiwei
Wang, Ning
Chen, Wanjing
Huang, Qiang
author_sort Zheng, Hao
collection PubMed
description BACKGROUND: The use of octreotide prophylaxis following pancreatic surgery is controversial. We aimed to evaluate the effectiveness of octreotide for the prevention of postoperative complications after pancreatic surgery through this systematic review and meta-analysis. METHODS: Literature databases (including the MEDLINE, EMBASE, and Cochrane databases) were searched systematically for relevant articles. Only randomized controlled trials (RCTs) were eligible for inclusion in our research. We extracted the basic information regarding the patients, intervention procedures, and all complications after pancreatic surgery and then performed the meta-analysis. RESULTS: Thirteen RCTs involving 2006 patients were identified. There were no differences between the octreotide group and the placebo group with regard to pancreatic fistulas (PFs) (relative risk [RR] = 0.79, 95% confidence interval [CI] = 0.62–0.99, P = .05), clinically significant PFs (RR = 1.01, 95% CI = 0.68–1.50, P = .95), mortality (RR = 1.21, 95% CI = 0.78–1.88, P = .40), biliary leakage (RR 0.84, 95% CI = 0.39–1.82, P = .66), delayed gastric emptying (RR = 0.83, 95% CI = 0.54–1.27, P = .39), abdominal infection (RR = 1.00, 95% CI = 0.66–1.52, P = 1.00), bleeding (RR = 1.16, 95% CI = 0.78–1.72, P = .46), pulmonary complications (RR = 0.73, 95% CI = 0.45–1.18, P = .20), overall complications (RR = 0.80, 95% CI = 0.64–1.01, P = .06), and reoperation rates (RR = 1.18, 95% CI = 0.77–1.81, P = .45). In the high-risk group, octreotide was no more effective at reducing PF formation than placebo (RR = 0.81, 95% CI = 0.67–1.00, P = .05). In addition, octreotide had no influence on the incidence of PF (RR = 0.38, 95% CI = 0.14–1.05, P = .06) after distal pancreatic resection and local pancreatic resection. CONCLUSION: The present best evidence suggests that prophylactic use of octreotide has no effect on reducing complications after pancreatic resection.
format Online
Article
Text
id pubmed-6756593
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67565932019-10-07 An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection Zheng, Hao Qin, Jiwei Wang, Ning Chen, Wanjing Huang, Qiang Medicine (Baltimore) 7100 BACKGROUND: The use of octreotide prophylaxis following pancreatic surgery is controversial. We aimed to evaluate the effectiveness of octreotide for the prevention of postoperative complications after pancreatic surgery through this systematic review and meta-analysis. METHODS: Literature databases (including the MEDLINE, EMBASE, and Cochrane databases) were searched systematically for relevant articles. Only randomized controlled trials (RCTs) were eligible for inclusion in our research. We extracted the basic information regarding the patients, intervention procedures, and all complications after pancreatic surgery and then performed the meta-analysis. RESULTS: Thirteen RCTs involving 2006 patients were identified. There were no differences between the octreotide group and the placebo group with regard to pancreatic fistulas (PFs) (relative risk [RR] = 0.79, 95% confidence interval [CI] = 0.62–0.99, P = .05), clinically significant PFs (RR = 1.01, 95% CI = 0.68–1.50, P = .95), mortality (RR = 1.21, 95% CI = 0.78–1.88, P = .40), biliary leakage (RR 0.84, 95% CI = 0.39–1.82, P = .66), delayed gastric emptying (RR = 0.83, 95% CI = 0.54–1.27, P = .39), abdominal infection (RR = 1.00, 95% CI = 0.66–1.52, P = 1.00), bleeding (RR = 1.16, 95% CI = 0.78–1.72, P = .46), pulmonary complications (RR = 0.73, 95% CI = 0.45–1.18, P = .20), overall complications (RR = 0.80, 95% CI = 0.64–1.01, P = .06), and reoperation rates (RR = 1.18, 95% CI = 0.77–1.81, P = .45). In the high-risk group, octreotide was no more effective at reducing PF formation than placebo (RR = 0.81, 95% CI = 0.67–1.00, P = .05). In addition, octreotide had no influence on the incidence of PF (RR = 0.38, 95% CI = 0.14–1.05, P = .06) after distal pancreatic resection and local pancreatic resection. CONCLUSION: The present best evidence suggests that prophylactic use of octreotide has no effect on reducing complications after pancreatic resection. Wolters Kluwer Health 2019-09-20 /pmc/articles/PMC6756593/ /pubmed/31567967 http://dx.doi.org/10.1097/MD.0000000000017196 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 7100
Zheng, Hao
Qin, Jiwei
Wang, Ning
Chen, Wanjing
Huang, Qiang
An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
title An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
title_full An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
title_fullStr An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
title_full_unstemmed An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
title_short An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
title_sort updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756593/
https://www.ncbi.nlm.nih.gov/pubmed/31567967
http://dx.doi.org/10.1097/MD.0000000000017196
work_keys_str_mv AT zhenghao anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT qinjiwei anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT wangning anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT chenwanjing anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT huangqiang anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT zhenghao updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT qinjiwei updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT wangning updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT chenwanjing updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection
AT huangqiang updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection